Sirona Biochem Announces Cfda Approval Of Sglt2 Inhibitor For Phase I Clinical Trial | Latest News RSS feed

Sirona Biochem Announces Cfda Approval Of Sglt2 Inhibitor For Phase I Clinical Trial - Latest News


Sirona Biochem Announces CFDA Approval of SGLT2 Inhibitor for Phase I Clinical Trial

July 12, 2018 08:00 ET | Source: Sirona Biochem Corp. VANCOUVER, British Columbia, July 12, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V:SBM) (FSE:ZSB) (the “Company”) announced today that par... read more

Sirona Biochem Announces Receipt of $500,000 US Milestone Payment

VANCOUVER, BC--(Marketwired - January 29, 2018) - Sirona Biochem Corp. (TSX VENTURE ... China Food and Drug Administration (CFDA) approval of the IND filing, which will lead to a clinical trial of Sir... read more

China Biotech In Review: Eli Lilly Joins The Big Pharmas Accused Of Bribing In China

The proceeds will be used to fund the US-China development of MRX-I, which has completed a Phase I clinical trial ... treatment from Sirona Biochem of Canada. The molecule is a member of a new class o... read more

Looking for another news?


Sirona Biochem Corp Ohlson Score (TTM):

Created by James Ohlson in the 1980s, the Ohlson Score uses items from the financial statement to predict the likelihood of a firm's bankruptcy. The O-Score breaks it down into nine different approxim... read more


Sirona Biochem Announces Results of AGM & CEO Update

VANCOUVER, BC--(Marketwired - December 19, 2017) - Sirona Biochem Corp. (TSX VENTURE: SBM) (ZSB.F) (ZSB.DE) (the "Company") announces that all ... months to approve the filing. Approval for the Phase ... read more

Sirona Biochem Announces Receipt of $500,000 US Milestone Payment

VANCOUVER, BC--(Marketwired - January 29, 2018) - Sirona Biochem Corp. (TSX VENTURE ... China Food and Drug Administration (CFDA) approval of the IND filing, which will lead to a clinical trial of Sir... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us